000 | 01958 a2200493 4500 | ||
---|---|---|---|
005 | 20250516073506.0 | ||
264 | 0 | _c20120628 | |
008 | 201206s 0 0 eng d | ||
022 | _a1098-6596 | ||
024 | 7 |
_a10.1128/AAC.05131-11 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMcGillivray, Shauna M | |
245 | 0 | 0 |
_aPharmacological inhibition of the ClpXP protease increases bacterial susceptibility to host cathelicidin antimicrobial peptides and cell envelope-active antibiotics. _h[electronic resource] |
260 |
_bAntimicrobial agents and chemotherapy _cApr 2012 |
||
300 |
_a1854-61 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAmino Acid Sequence |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
650 | 0 | 4 |
_aAntimicrobial Cationic Peptides _xpharmacology |
650 | 0 | 4 |
_aBacillus anthracis _xdrug effects |
650 | 0 | 4 |
_aBacteria _xdrug effects |
650 | 0 | 4 |
_aCell Membrane _xmetabolism |
650 | 0 | 4 | _aDrug Resistance, Bacterial |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 |
_aEndopeptidase Clp _xantagonists & inhibitors |
650 | 0 | 4 |
_aEscherichia coli Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aMethicillin-Resistant Staphylococcus aureus _xdrug effects |
650 | 0 | 4 | _aMolecular Sequence Data |
650 | 0 | 4 |
_aProtease Inhibitors _xpharmacology |
650 | 0 | 4 |
_aStaphylococcus aureus _xdrug effects |
650 | 0 | 4 |
_aTetrazoles _xpharmacology |
650 | 0 | 4 | _aCathelicidins |
700 | 1 | _aTran, Dan N | |
700 | 1 | _aRamadoss, Nitya S | |
700 | 1 | _aAlumasa, John N | |
700 | 1 | _aOkumura, Cheryl Y | |
700 | 1 | _aSakoulas, George | |
700 | 1 | _aVaughn, Micah M | |
700 | 1 | _aZhang, Dawn X | |
700 | 1 | _aKeiler, Kenneth C | |
700 | 1 | _aNizet, Victor | |
773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 56 _gno. 4 _gp. 1854-61 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.05131-11 _zAvailable from publisher's website |
999 |
_c21468286 _d21468286 |